Talphera (TLPH) Change in Cash (2010 - 2026)
Talphera (TLPH) posted Change in Cash of -$3.1 million for Q2 2026, down 48.77% on a QoQ basis from -$2.1 million in Q1 2026, and down 319.6% year-over-year from $1.4 million in Q2 2025.
Analysis
Talphera (TLPH) Change in Cash (2010 - 2026) Analysis & Trends
Talphera has reported Change in Cash for 17 years, with the latest figure at -$3.1 million in Q2 2026.
- On a quarterly basis, Change in Cash fell 319.6% year-over-year to -$3.1 million in Q2 2026; TTM through Jun 2026 was -$6.0 million, a 8.79% increase from a year earlier, with the FY2025 full-year figure at -$3.0 million, down 194.49% from the prior year.
- Change in Cash was -$3.1 million for Q2 2026 at Talphera, down from -$2.1 million in the prior quarter.
- The five-year high for Change in Cash was $9.2 million in Q1 2022, with the low at -$7.7 million in Q4 2023.
- Average Change in Cash over 5 years is -$662277.8, with a median of -$2.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Change in Cash surged 518.26% in 2022, then slumped 401.53% in 2023.
- Over 5 years, Change in Cash stood at $2.5 million in 2022, then plunged by 401.53% to -$7.7 million in 2023, then soared by 70.61% to -$2.3 million in 2024, then surged by 208.12% to $2.4 million in 2025, then slumped by 226.43% to -$3.1 million in 2026.
- The last three Change in Cash figures came in at -$3.1 million (Q2 2026), -$2.1 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -4.45 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 649.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -504.60 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -185.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -170.44 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | -3.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.08 Mn |
| Mar 31, 2026 | -2.07 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | -3.33 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | -3.48 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.31 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Dec 31, 2023 | -7.67 Mn |
| Sep 30, 2023 | 5.98 Mn |
| Jun 30, 2023 | -5.94 Mn |
| Mar 31, 2023 | -6.92 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | -2.43 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Mar 31, 2022 | 9.16 Mn |
| Dec 31, 2021 | -608,000.00 |
| Sep 30, 2021 | -13.06 Mn |